Home › Ewing Sarcoma › Colorado › Aurora

Ewing Sarcoma clinical trials in Aurora, CO

6 studies for Ewing Sarcoma are looking for participants at sites in and around Aurora (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

RecruitingPhase 1/2

Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016), Aurora

6 Months – 25 Years · All sexes · Updated Sep 17, 2026 · NCT06395103

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

RecruitingPhase 1

University of Colorado Hospital, Aurora

Ages 12 to 85 · All sexes · Updated Sep 8, 2026 · NCT03715933

Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas

RecruitingPhase 1

Children's Hospital Colorado, Aurora

Ages 5 to 40 · All sexes · Updated Sep 3, 2026 · NCT06156410

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

RecruitingPhase 1/2

Children's Hospital Colorado, Aurora

12 Months – 30 Years · All sexes · Updated Aug 25, 2026 · NCT04851119

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

RecruitingPhase 1/2

Children's Hospital Colorado, Aurora

12 Months – 30 Years · All sexes · Updated May 19, 2026 · NCT04901702

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

RecruitingPhase 2

Children's Hospital of Colorado, Aurora

18 Months – 40 Years · All sexes · Updated Aug 12, 2025 · NCT05135975

Ewing Sarcoma trials in other cities

Other studies in Aurora

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.